Authors
Loading...
Randomized trial reveals lineage heterogeneity in bone marrow mesenchymal stem cells, suggesting biomarkers for disease progression.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: